{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T23:08:49Z","timestamp":1788995329418,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["25X010301366"],"award-info":[{"award-number":["25X010301366"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404292"],"award-info":[{"award-number":["82404292"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Hospital Administration","award":["YLXX24AIA001"],"award-info":[{"award-number":["YLXX24AIA001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fractional exhaled nitric oxide (FeNO) is a non-invasive biomarker of type 2 inflammation with potential for personalized asthma management. However, the longitudinal patterns of FeNO and their association with childhood asthma control remain insufficiently characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cohort study enrolled children with newly diagnosed asthma from Shanghai Children\u2019s Medical Center. Participants underwent baseline assessments and serial FeNO measurements at diagnosis and at 3-month intervals over 12 months. Asthma control was assessed at 12 months using Global Initiative for Asthma (GINA) criteria. Longitudinal trajectories of FeNO were identified using group-based trajectory modeling (GBTM). Associations of time-specific FeNO levels and FeNO trajectory group with uncontrolled asthma at 12 months were analyzed using logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 142 children (mean age 6.92\u2009\u00b1\u20092.08 years; 71.1% male), 125 (88.0%) achieved controlled asthma and 17 (12.0%) had uncontrolled asthma at 12 months. Elevated FeNO at 3 and 12 months was significantly associated with increased odds of uncontrolled asthma after adjusting for covariates. Longitudinal FeNO levels showed two distinct trajectories: low-stable (80.3% of participants) and high-rising (19.7%). Compared with the low-stable group, the high-rising group had significantly older age, later wheezing onset, higher serum total immunoglobulin E (IgE) and eosinophil percentages (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Children in the high-rising trajectory group had higher odds of uncontrolled asthma (OR\u2009=\u20095.86; 95% CI: 1.28\u201329.57;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.025).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Elevated FeNO levels during follow-up and a high-rising FeNO trajectory are associated with uncontrolled asthma at 12 months in children with newly diagnosed asthma. Longitudinal FeNO monitoring may help identify children at increased risk of poor asthma control and support more individualized asthma management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13223-026-01044-y","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:15:04Z","timestamp":1781284504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Longitudinal FeNO monitoring in pediatric asthma: association of FeNO and its trajectory patterns with asthma control status"],"prefix":"10.1186","volume":"22","author":[{"given":"Xiaolan","family":"Ying","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"1044_CR1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2213-2600(25)00003-7","volume":"13","author":"J Oh","year":"2025","unstructured":"Oh J, Kim S, Kim MS, Abate YH, Abd ElHafeez S, Abdelkader A, Abdi P, Abdulah DM, Aboagye RG, Abolhassani H. Global, regional, and national burden of asthma and atopic dermatitis, 1990\u20132021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. lancet respiratory Med. 2025;13:425\u201346.","journal-title":"lancet respiratory Med"},{"key":"1044_CR2","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/j.jaci.2021.10.001","volume":"148","author":"RL Miller","year":"2021","unstructured":"Miller RL, Grayson MH, Strothman K. Advances in asthma: New understandings of asthma\u2019s natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol. 2021;148:1430\u201341.","journal-title":"J Allergy Clin Immunol"},{"key":"1044_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1183\/16000617.0082-2015","volume":"25","author":"FM De Benedictis","year":"2016","unstructured":"De Benedictis FM, Attanasi M. Asthma in childhood. Eur Respiratory Rev. 2016;25:41\u20137.","journal-title":"Eur Respiratory Rev"},{"key":"1044_CR4","unstructured":"Global Initiative for Asthma (GINA): Global Strategy for Asthma Management and Prevention. 2025. Accessed May 4, 2026. https:\/\/ginasthma.org\/2025-gina-strategy-report\/"},{"key":"1044_CR5","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","volume":"184","author":"RA Dweik","year":"2011","unstructured":"Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, Plummer AL, Taylor DR. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184:602\u201315.","journal-title":"Am J Respir Crit Care Med"},{"key":"1044_CR6","doi-asserted-by":"publisher","unstructured":"Spallarossa D, Battistini E, Silvestri M, Sabatini F, Biraghi MG, Rossi GA. Time-dependent changes in orally exhaled nitric oxide and pulmonary functions induced by inhaled corticosteroids in childhood asthma. J Asthma. 2001;38(7):545\u201353. https:\/\/doi.org\/10.1081\/jas-100107119.","DOI":"10.1081\/jas-100107119"},{"key":"1044_CR7","doi-asserted-by":"publisher","first-page":"e617","DOI":"10.1097\/MJT.0000000000000423","volume":"25","author":"SJ Gao","year":"2018","unstructured":"Gao SJ, Ge YP, Zhang CJ. Correlation Between Fractional Exhaled Nitric Oxide Levels and Efficacy of Inhaled Corticosteroids in Children With Bronchial Asthma. Am J Ther. 2018;25:e617\u201325.","journal-title":"Am J Ther"},{"key":"1044_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5414\/CP202570","volume":"55","author":"SS Yin","year":"2017","unstructured":"Yin SS, Liu H, Gao X. Elevated fractional exhaled nitric oxide (FeNO) is a clinical indicator of uncontrolled asthma in children receiving inhaled corticosteroids. Int J Clin Pharmacol Ther. 2017;55:66\u201377.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"1044_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jaci.2023.09.044","volume":"154","author":"LB Bacharier","year":"2024","unstructured":"Bacharier LB, Pavord ID, Maspero JF, Jackson DJ, Fiocchi AG, Mao X, Jacob-Nara JA, Deniz Y, Laws E, Mannent LP, et al. Blood eosinophils and fractional exhaled nitric oxide are prognostic and predictive biomarkers in childhood asthma. J Allergy Clin Immunol. 2024;154:101\u201310.","journal-title":"J Allergy Clin Immunol"},{"key":"1044_CR10","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/ppul.25333","volume":"56","author":"N Diamant","year":"2021","unstructured":"Diamant N, Amirav I, Armoni-Domany K, Sadot E, Shapira U, Cahal M, Be\u2019er M, Rochman M, Lavie M. High fractional exhaled nitric oxide levels in asthma patients: Does size matter? Pediatr Pulmonol. 2021;56:1449\u201354.","journal-title":"Pediatr Pulmonol"},{"key":"1044_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.18176\/jiaci.0317","volume":"29","author":"P Kalm-Stephens","year":"2019","unstructured":"Kalm-Stephens P, Nordvall L, Janson C, Neuman \u00c5, Malinovschi A, Alving K. Elevated Exhaled Nitric Oxide in Adolescents Is Associated With Incident Allergic Symptoms: A Prospective Cohort Study. J Investig Allergol Clin Immunol. 2019;29:231\u20138.","journal-title":"J Investig Allergol Clin Immunol"},{"key":"1044_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.rmed.2018.10.009","volume":"145","author":"J Zeng","year":"2018","unstructured":"Zeng J, Chen Z, Hu Y, Hu Q, Zhong S, Liao W. Asthma control in preschool children with small airway function as measured by IOS and fractional exhaled nitric oxide. Respir Med. 2018;145:8\u201313.","journal-title":"Respir Med"},{"key":"1044_CR13","first-page":"e35289","volume":"15","author":"MO Al Ghobain","year":"2023","unstructured":"Al Ghobain MO, Alsubaie AS, Aljumah WA, Alrumayh FM, Aldawsari KF, Alqahtani AM, Alotaibi SN. The Correlation Between Fractional Exhaled Nitric Oxide (FeNO), Blood Eosinophil Count, Immunoglobulin E Levels, and Spirometric Values in Patients With Asthma. Cureus. 2023;15:e35289.","journal-title":"Cureus"},{"key":"1044_CR14","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/ppul.24790","volume":"55","author":"S Zheng","year":"2020","unstructured":"Zheng S, Hu Y, Chen Z, Wang M, Liao W. Predicting asthma exacerbation by impulse oscillometry evaluation of small airway function and fractional exhaled nitric oxide in preschool children. Pediatr Pulmonol. 2020;55:1601\u20137.","journal-title":"Pediatr Pulmonol"},{"key":"1044_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1080\/02770903.2022.2073549","volume":"60","author":"L Chen","year":"2023","unstructured":"Chen L, Agalliu I, Roth A, Rastogi D. Association of fractional exhaled nitric oxide with asthma morbidity in urban minority children. J Asthma. 2023;60:553\u201364.","journal-title":"J Asthma"},{"key":"1044_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.chest.2018.10.009","volume":"155","author":"S Fielding","year":"2019","unstructured":"Fielding S, Pijnenburg M, de Jongste JC, Pike KC, Roberts G, Petsky H, Chang AB, Fritsch M, Frischer T, Szefler S, et al. Change in FEV(1) and Feno Measurements as Predictors of Future Asthma Outcomes in Children. Chest. 2019;155:331\u201341.","journal-title":"Chest"},{"key":"1044_CR17","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ppul.24630","volume":"55","author":"S Fielding","year":"2020","unstructured":"Fielding S, Pijnenburg M, de Jongste J, Pike K, Roberts G, Petsky H, Chang AB, Fritsch M, Frischer T, Szefler S, et al. What is a clinically meaningful change in exhaled nitric oxide for children with asthma? Pediatr Pulmonol. 2020;55:599\u2013606.","journal-title":"Pediatr Pulmonol"},{"key":"1044_CR18","doi-asserted-by":"crossref","unstructured":"Boulet LP, Reddel HK, Bateman E, Pedersen S, FitzGerald JM, O\u2019Byrne PM. The Global Initiative for Asthma (GINA): 25 years later. Eur Respir J 2019, 54.","DOI":"10.1183\/13993003.00598-2019"},{"key":"1044_CR19","doi-asserted-by":"publisher","first-page":"1043047","DOI":"10.3389\/fped.2022.1043047","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu L, Ma H, Yuan S, Zhang J, Wu J, Dilimulati M, Wang Y, Shen S, Zhang L, Lin J, Yin Y. Prognosis of bronchial asthma in children with different pulmonary function phenotypes: A real-world retrospective observational study. Front Pediatr. 2022;10:1043047.","journal-title":"Front Pediatr"},{"key":"1044_CR20","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","volume":"171","author":"ATS\/ERS recommendations for standardized procedures for the","year":"2005","unstructured":"ATS\/ERS recommendations for standardized procedures for the. online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171:912\u201330.","journal-title":"Am J Respir Crit Care Med"},{"key":"1044_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin DS. Group-based trajectory modeling: an overview. Ann Nutr Metab. 2014;65:205\u201310.","journal-title":"Ann Nutr Metab"},{"key":"1044_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338.","journal-title":"Annu Rev Clin Psychol"},{"key":"1044_CR23","doi-asserted-by":"publisher","first-page":"2382377","DOI":"10.1080\/07853890.2024.2382377","volume":"56","author":"JS Afriyie-Mensah","year":"2024","unstructured":"Afriyie-Mensah JS, Domoyeri P, Antwi-Boasiako C, Aryee R, Dankwah GB, Ntiamoah M, Dzudzor B, Kusi-Mensah Y, Hayfron-Benjamin CF. Relationship between fraction of exhaled nitric oxide and peripheral eosinophilia in asthma. Ann Med. 2024;56:2382377.","journal-title":"Ann Med"},{"key":"1044_CR24","doi-asserted-by":"crossref","unstructured":"Czubaj-Kowal M, Nowicki GJ, Kurzawa R, Polak M, \u015alusarska B. Factors Influencing the Concentration of Exhaled Nitric Oxide (FeNO) in School Children Aged 8-9-Years-Old in Krakow, with High FeNO Values\u2009\u2265\u200920 ppb. Med (Kaunas) 2022, 58.","DOI":"10.3390\/medicina58020146"},{"key":"1044_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.jaci.2005.03.020","volume":"115","author":"F Buchvald","year":"2005","unstructured":"Buchvald F, Baraldi E, Carraro S, Gaston B, De Jongste J, Pijnenburg MW, Silkoff PE, Bisgaard H. Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years. J Allergy Clin Immunol. 2005;115:1130\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"1044_CR26","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1183\/09031936.00013911","volume":"39","author":"TC Yao","year":"2012","unstructured":"Yao TC, Lee WI, Ou LS, Chen LC, Yeh KW, Huang JL. Reference values of exhaled nitric oxide in healthy Asian children aged 5 to 18 years. Eur Respir J. 2012;39:378\u201384.","journal-title":"Eur Respir J"},{"key":"1044_CR27","first-page":"479","volume":"18","author":"A Dabbaghzadeh","year":"2019","unstructured":"Dabbaghzadeh A, Tavakol M, Gharagozlou M. The Role of FENO in Comparison to Spirometry and ACT in Control of Children Asthma Symptoms. Iran J Allergy Asthma Immunol. 2019;18:479\u201386.","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"1044_CR28","doi-asserted-by":"publisher","first-page":"603312","DOI":"10.3389\/fimmu.2020.603312","volume":"11","author":"C Pelaia","year":"2020","unstructured":"Pelaia C, Crimi C, Vatrella A, Tinello C, Terracciano R, Pelaia G. Molecular Targets for Biological Therapies of Severe Asthma. Front Immunol. 2020;11:603312.","journal-title":"Front Immunol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-026-01044-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-026-01044-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:52:27Z","timestamp":1788994347000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13223-026-01044-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1044"],"URL":"https:\/\/doi.org\/10.1186\/s13223-026-01044-y","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Shanghai Children\u2019s Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine (SCMCIRB-K2017007). All procedures performed in this study were in accordance with the Declaration of Helsinki. Informed written consent was obtained from all parents\/carers of the participants included in the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"49"}}